Opus Genetics Inc Share Price

NASDAQ: IRD

Mid Cap

$1.48

+0.05

(+3.50%)

as on September 19, 2025 at 1:29 am IST

$₹

Opus Genetics Inc Stock Performance

as on September 19, 2025 at 1:29 am IST

Day's Low
Day's High
$1.41
Day's Price Range
$1.49
$1.48
4.73%
Downside
0.68%
Upside
52 Week's Low
52 Week's High
$0.65
52-Week Price Range
$1.75
$1.48
56.08%
Downside
18.24%
Upside

Opus Genetics Inc share price movements today

Previous Close: $1.43
Open: $1.42
Volume: 850.1K
Day's Low - High: $1.41 - $1.49
52 Week Low - High: $0.65 - $1.75

Opus Genetics Inc Historical Returns

1 Month Return: + 24.35 %
3 Month Return: + 53.55 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Opus Genetics Inc Stock Fundamentals & Key Indicators

Check Opus Genetics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$83.9M

EPS (TTM)

-1.09

Dividend Yield

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

Return On Equity TTM

2251481800.00%

Opus Genetics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Opus Genetics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Opus Genetics Inc	NA	$83.9M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	241.54%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Opus Genetics Inc Stock's Interest Amongst Investors

Search interest for Opus Genetics Inc Stock has increased by 175% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 20, 2025 to September 19, 2025

Change:175% versus previous 30 day period

Opus Genetics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	1	3	11	1	1	1	3	4	4	2
Gross Profit	1	3	11	1	1	1	3	4	4	-
Operating Income	-6	-5	6	-5	-7	-8	-8	-38	-9	-8
EBITDA	-6	-5	6	-4	-7	-8	-7	-35	-6	-8
Interest Expense	-	-	1	-	-	-	-	-	1	0
Depreciation	-	0	0	0	-	-	-	0	0	0
Income Before Tax	-5	-4	5	-4	-7	-7	-7	-35	-8	-7
Income Tax Expense	-	-	0	0	-	-	-	-	-	-
Net Income	-5	-4	5	-4	-7	-7	-7	-35	-8	-7
Net Profit Margin	-331.10%	-135.03%	46.59%	-283.56%	-415.31%	-698.29%	-194.62%	-816.71%	-187.51%	-257.46%

Opus Genetics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	0	39	19	10
Gross Profit	0	0	39	19	10
Operating Income	-19	-22	18	-10	-62
EBITDA	-17	-56	18	-9	-57
Interest Expense	6	0	0	1	-
Depreciation	0	0	0	0	0
Income Before Tax	-24	-56	18	-9	-57
Income Tax Expense	-	-	0	0	-
Net Income	-24	-56	17	-9	-57
Net Profit Margin	0.00%	-9625.30%	44.89%	-52.42%	-523.40%

Opus Genetics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-4	5	-4	-7	-7	-7	-35	-8	-7
Operating Cash Flow	0	-3	4	-5	-7	-5	-7	-8	-10
Investing Cash Flow	-	-	-	-	-	-	1	-	-
Financing Cash Flow	-	5	3	2	1	0	0	20	0
Change in Cash	0	2	8	-3	-5	-4	-6	11	-9

Opus Genetics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-24	-56	17	-9	-57
Operating Cash Flow	-6	-19	14	-1	-25
Investing Cash Flow	0	0	-	-	1
Financing Cash Flow	21	27	3	8	4
Change in Cash	14	8	18	7	-20

Insights on Opus Genetics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, IRD stock has moved up by 24.3%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 60.9%

About Opus Genetics Inc

Opus Genetics, Inc. is a clinical-stage ophthalmic biotechnology company. The Company is engaged in developing gene therapies for the treatment of inherited retinal diseases (IRDs) and other types of therapies for additional ophthalmic disorders. The Company’s pipeline includes adeno-associated virus (AAV)-based investigational gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA) and retinitis pigmentosa. Its pipeline also includes OPGx-BEST1 investigational gene therapy, designed to address mutations in the BEST1 gene, which is associated with retinal degeneration. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist being investigated to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 being investigated to slow the progression of non-proliferative diabetic retinopathy.

Organisation	Opus Genetics Inc
Headquarters	8 Davis Drive, Durham, NC, United States, 27709
CEO	Mr. George Magrath M.B.A., M.D., M.S.
E-voting on shares	Click here to vote

Key Management of Opus Genetics Inc

Name	Title
Mr. Robert E. Gagnon	CFO & Principal Accounting Officer
Mr. Joseph K. Schachle MBA	Chief Operating Officer
Mr. Bernhard Hoffmann M.B.A.	Senior Vice President of Corporate Development & Secretary
Ms. Bindu Manne	Head of Market Development & Commercialization
Mr. Erik Sims	Director & Corporate Controller
Mr. George Magrath M.B.A., M.D., M.S.	CEO & Director
Dr. Benjamin R. Yerxa Ph.D.	President & Director
Dr. Ashwath Jayagopal Ph.D.	Chief Scientific & Development Officer

FAQs

What is Opus Genetics Inc share price today?

Opus Genetics Inc share price today is $1.48 as on September 19, 2025 at 1:29 am IST at the close of the market. Opus Genetics Inc share today touched a day high of $1.49 and a low of $1.41.

What is the 52 week high and 52 week low for Opus Genetics Inc share?

Opus Genetics Inc share touched a 52 week high of $1.75 on June 2, 2025 and a 52 week low of $0.65 on April 10, 2025. Opus Genetics Inc stock price today i.e. September 19, 2025 at 1:29 am IST is closed at $1.48,which is 15.43% down from its 52 week high and 127.69% up from its 52 week low.

What is Opus Genetics Inc's market capitalisation today?

Opus Genetics Inc market capitalisation is $0.00T as on September 19, 2025 at 1:29 am IST.

How to invest in Opus Genetics Inc Stock (IRD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Opus Genetics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Opus Genetics Inc Shares that will get you 1.0135 shares as per Opus Genetics Inc share price of $1.48 per share as on September 19, 2025 at 1:29 am IST.

What is the minimum amount required to buy Opus Genetics Inc Stock (IRD) from India?

Indian investors can start investing in Opus Genetics Inc (IRD) shares with as little as ₹88.114 or $1 (as of September 19, 2025 at 2:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Opus Genetics Inc stock (as per the Rupee-Dollar exchange rate as on September 19, 2025 at 2:39 am IST). Based on Opus Genetics Inc share’s latest price of $1.48 as on September 19, 2025 at 1:29 am IST, you will get 6.7568 shares of Opus Genetics Inc. Learn more about fractional shares .